Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors
Seodhna M. Lynch, Niamh M. Russell, Stephen Barron, Chan-ju A. Wang, Tony Loughman, Peter Dynoodt, Bozena Fender, Cesar Lopez-ruiz, Anthony O'grady, Katherine M. Sheehan, Joanna Fay, Verena Amberger-murphy, Anurati Saha, Rut Klinger, Claudia A. Gonzalez, Nebras Al-attar, Arman Rahman, Desmond O'leary, Fiona T. Lanigan, Adrian P. BrackenJohn Crown, Catherine M. Kelly, Darran P. O'connor, William M. Gallagher
Dive into the research topics of 'Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors'. Together they form a unique fingerprint.